Vulnerability · Published Jul 23, 2024 · Assigned by GitHub_M

CVE-2024-41668cBioPortal Proxy Endpoint Vulnerabliity

High 8.3

In plain English

A high-severity server-side request forgery in cbioportal from cBioPortal. Proof-of-concept exploit code is public. The chance it is exploited in the next 30 days is estimated at 0.6% (higher than 48% of all known vulnerabilities).

Severity (CVSS 3.1)8.3High

Exploit odds (30 days)0.6%top 52.1% of all CVEs

Exploited in the wildNo reportsCISA SSVC: poc

Attack toolingNoneno public tooling known

Official description

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

Affected products (as reported)

Vendor	Product	Versions
cBioPortal	cbioportal	< 6.0.12

Weakness: CWE-918 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

References

https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm x_refsource_CONFIRM
https://github.com/cBioPortal/cbioportal/pull/10884 x_refsource_MISC
https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a1594680bbbcd5 x_refsource_MISC
https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12 x_refsource_MISC
https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004 x_refsource_MISC